藍黛科技(002765.SZ):持股1.58%股東晟方投資擬減持不超0.63%股份
格隆匯3月16日丨藍黛科技(002765.SZ)公佈,公司持股1.58%的股東晟方投資計劃自該公吿披露之日後,通過大宗交易或集中競價方式合計減持公司股票不超過364.019萬股,即不超過公司總股本的0.63%。
如通過大宗交易進行減持的,將於該減持計劃公吿之日後進行,減持時間為自2021年3月18日-9月17日;通過集中競價進行減持的,將於該減持計劃公吿之日起15個交易日之後進行,即減持時間為自2021年4月9日-10月8日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.